MRI Versus Breast-Specific Gamma Imaging (BSGI) in Newly Diagnosed Ductal Cell Carcinoma-in-situ: A Prospective Head-to-Head Trial
Annals of Surgical Oncology, 07/15/2011
Keto JL et al. – Although BSGI has previously been shown to be as sensitive as MRI for detecting known invasive breast carcinoma, this study shows that breast–specific gamma imaging (BSGI)I is equally as sensitive as MRI at detecting newly diagnosed ductal carcinoma–in–situ (DCIS). As a result of the limited number of patients enrolled onto the study, larger prospective studies need to be performed to determine the true sensitivity and specificity of BSGI.